{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:05:00Z","timestamp":1792785900348,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"China Association Against Epilepsy","award":["2017007"],"award-info":[{"award-number":["2017007"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601038"],"award-info":[{"award-number":["81601038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013318","name":"Shanxi Science and Technology Department","doi-asserted-by":"crossref","award":["2014021038-4"],"award-info":[{"award-number":["2014021038-4"]}],"id":[{"id":"10.13039\/501100013318","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanxi Medical University Innovation and Entrepreneurship Foundation of China","award":["057602"],"award-info":[{"award-number":["057602"]}],"id":[{"id":"https:\/\/ror.org\/0265d1010","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.eplepsyres.2018.03.009","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T02:53:05Z","timestamp":1520563985000},"page":"45-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus"],"prefix":"10.1016","volume":"142","author":[{"given":"Rui-Fang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Fang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"H\u00f6lscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0005","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12035-014-8648-2","article-title":"Post-Seizure \u03b1-tocopherol treatment decreases neuroinflammation and neuronal degeneration induced by status epilepticus in rat hippocampus","volume":"50","author":"Ambrogini","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1528-1167.2011.03033.x","article-title":"Inflammation in epilepsy: clinical observations","volume":"52","author":"Aronica","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0015","first-page":"31585","article-title":"Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"6736","author":"Athauda","year":"2017","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.eplepsyres.2018.03.009_bib0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1528-1167.2010.02606.x","article-title":"Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA","volume":"51","author":"Auvin","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0025","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI68295","article-title":"Exenatide and the treatment of patients with Parkinson's disease","volume":"123","author":"Aviles-Olmos","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JPD-140364","article-title":"Motor and cognitive advantages persist 12 months after exenatide exposure in parkinson's disease","volume":"4","author":"Aviles-Olmos","year":"2014","journal-title":"J. Parkinson's Dis."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10787-017-0331-6","article-title":"Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease","volume":"25","author":"Badawi","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0040","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s11011-017-0059-4","article-title":"Beneficial effects of liraglutide (GLP1 analog) in the hippocampal inflammation","volume":"32","author":"Barreto-Vianna","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuroscience.2014.09.064","article-title":"Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia","volume":"281C","author":"Briyal","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0050","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1468-1331.2011.03420.x","article-title":"Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study","volume":"18","author":"Chen","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0055","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","article-title":"Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain","volume":"4","author":"Cork","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jneumeth.2008.04.019","article-title":"The pilocarpine model of temporal lobe epilepsy","volume":"172","author":"Curia","year":"2008","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0065","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/0929867320666131119152201","article-title":"Pathophysiogenesis of mesial temporal lobe epilepsy: is prevention of damage antiepileptogenic","volume":"21","author":"Curia","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0075","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.4049\/jimmunol.150.7.2964","article-title":"Exogenous Nitric oxide (NO) generation or IL-1b-induced intracellular NO production stimulates inhibitory auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase in RINm5F cells","volume":"150","author":"Diemmeler","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0080","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm.1878","article-title":"A role for leukocyte-endothelial adhesion mechanisms in epilepsy","volume":"14","author":"Fabene","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0085","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.expneurol.2007.05.014","article-title":"CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure","volume":"209","author":"Fitch","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0090","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/j.1528-1157.2000.tb01521.x","article-title":"Status epilepticus: risk factors and complications","volume":"41","author":"Fountain","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0095","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/j.1528-1167.2012.03666.x","article-title":"Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology","volume":"53","author":"Frigerio","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2016.00108","article-title":"In Alzheimer\u2019s disease, six-month treatment with GLP-1 analogue prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial","volume":"8","author":"Gejl","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2015.04.047","article-title":"Status epilepticus, blood\u2013brain barrier disruption, inflammation, and epileptogenesis","volume":"49","author":"Gorter","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/XCE.0000000000000087","article-title":"GLP-1 and GIP analogues as novel treatments for Alzheimer\u2019s and Parkinson\u2019s disease","volume":"5","author":"H\u00f6lscher","year":"2016","journal-title":"Cardiovasc. Endocrinol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0115","doi-asserted-by":"crossref","first-page":"e0120074","DOI":"10.1371\/journal.pone.0120074","article-title":"Preservation of the blood brain barrier and cortical neuronal tissue by liraglutide, a long acting glucagon-like-1 analogue, after experimental traumatic brain injury","volume":"10","author":"Hakon","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0120","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/WNR.0b013e32832fbf14","article-title":"Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system","volume":"20","author":"Hamilton","year":"2009","journal-title":"Neuroreport"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0125","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2015.12.052","article-title":"The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy","volume":"1634","author":"Hansen","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0130","first-page":"117","article-title":"Apoptosis regulators","volume":"7","author":"Harada","year":"2003","journal-title":"Rev. Clin. Exp. Hematol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0135","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/glia.22311","article-title":"Blood-brain barrier dysfunction, TGFbeta signaling, and astrocyte dysfunction in epilepsy","volume":"60","author":"Heinemann","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0140","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/ana.410440609","article-title":"Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus","volume":"44","author":"Hesdorffer","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0145","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"Holtkamp","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2015.09.035","article-title":"A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF","volume":"1634","author":"Ji","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2017.03.009","article-title":"Long-term outcome of refractory status epilepticus in adults: a retrospective population-based study","volume":"133","author":"Kantanen","year":"2017","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature07591","article-title":"Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis","volume":"457","author":"Kim","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-016-2678-1","article-title":"Neurochemical modulation involved in the beneficial effect of liraglutide, GLP-1 agonist on PTZ kindling epilepsy-induced comorbidities in mice","volume":"415","author":"Koshal","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0175","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s11064-016-1890-4","article-title":"Effect of liraglutide on corneal kindling epilepsy induced depression and cognitive impairment in mice","volume":"41","author":"Koshal","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0180","article-title":"Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0185","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/jnc.13169","article-title":"Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice","volume":"135","author":"Li","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12868-016-0272-9","article-title":"The GLP-1 receptor agonists exendin-4 and liraglutide alleviate oxidative stress and cognitive and micturition deficits induced by middle cerebral artery occlusion in diabetic mice","volume":"17","author":"Li","year":"2016","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2015.06.054","article-title":"Neuroprotective effects of lixisenatide and liraglutide in the MPTP mouse model of Parkinson\u2019s disease","volume":"303","author":"Liu","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0200","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/diacare.27.6.1335","article-title":"Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial","volume":"27","author":"Madsbad","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0205","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jad.2016.09.056","article-title":"Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: a pilot, open-label study","volume":"207","author":"Mansur","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0210","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.euroneuro.2017.08.433","article-title":"Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders","volume":"27","author":"Mansur","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0215","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2127","article-title":"Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures","volume":"16","author":"Maroso","year":"2010","journal-title":"Nat. Med."},{"issue":"Pt A","key":"10.1016\/j.eplepsyres.2018.03.009_bib0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer's disease","volume":"76","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0225","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug Liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease","volume":"31","author":"McClean","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0230","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2015.07.024","article-title":"Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP\/PS1 mice","volume":"293","author":"McClean","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0235","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0240","first-page":"143","article-title":"Cytokines in Parkinson's disease","volume":"58","author":"Nagatsu","year":"2000","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2010.09.003","article-title":"Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review","volume":"93","author":"Neligan","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2012.12.012","article-title":"The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain","volume":"700","author":"Parthsarathy","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eplepsyres.2004.10.003","article-title":"Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat","volume":"63","author":"Pitkanen","year":"2005","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuroscience.2012.11.005","article-title":"A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus","volume":"231","author":"Pouliot","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/745613","article-title":"Seizure-induced oxidative stress in temporal lobe epilepsy","author":"Puttachary","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0270","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0013-4694(72)90176-9","article-title":"Modification of seizure activity by electrical stimulation: I. after-discharge threshold","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0275","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.euroneuro.2008.06.008","article-title":"Experimentally induced various inflammatory models and seizure: understanding the role of cytokine in rat","volume":"18","author":"Rao","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0280","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nbd.2006.06.003","article-title":"The IL-1\u03b2 system in epilepsy-associated malformations of cortical development","volume":"24","author":"Ravizza","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0285","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1528-1167.2006.00590.x","article-title":"Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy","volume":"47","author":"Ravizza","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0290","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neulet.2011.02.040","article-title":"Inflammation and prevention of epileptogenesis","volume":"497","author":"Ravizza","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0295","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.brainresrev.2009.10.004","article-title":"Astrocyte dysfunction in epilepsy","volume":"63","author":"Seifert","year":"2010","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0300","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jnc.12469","article-title":"Neuroprotective and anti-apoptotic effects of Liraglutide on SH-SY5Y cells exposed to Methylglyoxal stress","volume":"128","author":"Sharma","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0310","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuroscience.2014.10.021","article-title":"Co-administration of subtherapeutic diazepam enhances neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus","volume":"284","author":"Trandafir","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0315","doi-asserted-by":"crossref","first-page":"E5665","DOI":"10.1073\/pnas.1604263113","article-title":"Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus","volume":"113","author":"Varvel","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0320","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1210\/en.2011-1895","article-title":"Antiapoptotic actions of exendin-4 against hypoxia and cytokines are augmented by CREB","volume":"153","author":"Velmurugan","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0325","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1073\/pnas.190206797","article-title":"Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice","volume":"97","author":"Vezzani","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.eplepsyres.2018.03.009_bib0330","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2008.01490.x","article-title":"Glia as a source of cytokines: implications for neuronal excitability and survival","volume":"49","author":"Vezzani","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0335","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","article-title":"Epilepsy and brain inflammation","volume":"244","author":"Vezzani","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1358\/dot.2009.45.2.1343904","article-title":"Liraglutide: a new treatment for type 2 diabetes","volume":"45","author":"Vilsboll","year":"2009","journal-title":"Drugs Today"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0350","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/glia.23008","article-title":"Microglia are less pro-inflammatory than myeloid infiltrates in the hippocampus of mice exposed to status epilepticus","volume":"64","author":"Vinet","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clineuro.2014.07.038","article-title":"Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit","volume":"126","author":"Vooturi","year":"2014","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0360","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuroscience.2014.12.021","article-title":"Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus","volume":"287","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0365","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jnr.22224","article-title":"Roles of astrocytes and microglia in seizure-induced aberrant neurogenesis in the hippocampus of adult rats","volume":"88","author":"Yang","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2017.06.029","article-title":"A novel GLP-1\/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinson's disease","author":"Yuan","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0375","doi-asserted-by":"crossref","first-page":"e0148827","DOI":"10.1371\/journal.pone.0148827","article-title":"An orally active allosteric GLP-1 receptor agonist is neuroprotective in cellular and rodent models of stroke","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.eplepsyres.2018.03.009_bib0380","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/brain\/awr032","article-title":"Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development","volume":"134","author":"Zurolo","year":"2011","journal-title":"Brain"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117305338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117305338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:39:18Z","timestamp":1760276358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121117305338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":76,"alternative-id":["S0920121117305338"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.03.009","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}